Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)
This study has been completed.
First Posted: October 10, 2012
Last Update Posted: January 19, 2015
Eli Lilly and Company
Information provided by (Responsible Party):